Evaluation of the cytotoxicity on breast cancer cell of extracts and compounds isolated from Hyptis pectinata (L.) poit

Nat Prod Res. 2020 Jan;34(1):102-109. doi: 10.1080/14786419.2019.1628747. Epub 2019 Jun 13.

Abstract

Hyptis pectinata is a herb popularly used in Brazil for the treatment of inflammations, pain, bacterial infections and cancer. In the present study, inflorescences (MPIn), leaves (MPL), branches (MPB), root (MPR) extracts and three compounds isolated from MPIn were assayed against breast tumor cell lines. The structures of the three compounds (pectinolide J, hyptolide and pectinolide E) were determined by means of spectroscopic analysis. Pectinolide J was isolated for the first time. The MPIn, MPL and MPR exhibited specific antiproliferative activity on tumor cell lines when compared to normal cell lines with IC50 of 52.01 ± 0.64, 45.91 ± 0.02 μg/mL and 82.84 ± 0.03 μg/mL, respectively. Although the isolated substances did not present good antiproliferative activity, when the three were associated, a greater biological effect was observed, suggesting a synergistic effect. Hyptolide (5.6 ± 0.4 μg/mL) showed IC50 sufficiently low to be considered as a drug prototype.

Keywords: Liquid chromatography; antiproliferative activity; cancer; pectinolides; synergistic effect.

MeSH terms

  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology
  • Brazil
  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Humans
  • Hyptis / chemistry*
  • Inhibitory Concentration 50
  • Plant Extracts / therapeutic use
  • Plant Extracts / toxicity*
  • Pyrones / isolation & purification
  • Pyrones / pharmacology

Substances

  • Antineoplastic Agents
  • Plant Extracts
  • Pyrones
  • hypurticin